Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XELADYS
2011-004211-23Phase 3Completed
- Sponsor
- CHU Amiens-Picardie
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tetrabenazine in tardive dyskinesia (TD), sponsored by CHU Amiens-Picardie. Started Oct 2011; status: completed.
02
Drugs
tetrabenazine
03
Conditions
tardive dyskinesia (TD)
Beyond the preview
Go deeper on 2011-004211-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004211-23.